Award notice, first published as solicitation
Bupropion HCL ER
SPE2D2-21-R-0105
Defense Logistics Agency, DLA Troop Support. Pharmaceutical Preparation Manufacturing.
Awarded
$23,278,523.95 on the award notice, October 6, 2022, contract SPE2D2-23-D-0002
Description
As published on SAM.gov.
Modification P00010 SPE2D223D0002 is issued to invoke option year 4 for Bupropion HCL ER National Contract. Modification P00009 SPE2D223D0002 is issued to incorporate clause 52.222-90, Addressing DEI Discrimination by Federal Contractors (DEVIATION 2026-O0040, REVISION 1) (APR 2026). Modification P00008 SPE2D223D0002 is issued to invoke option year 3 for Bupropion HCL ER National Contract.
Modification P00007 SPE2D223D0002 is issued in accordance with DoD Class Deviation 2025-O0003 and Class Deviation 2025-O0004 into subject solicitation. Modification P00006 SPE2D223D0002 is issued to invoke option year 2 for Bupropion HCL ER National Contract. Modification P00005 SPE2D223D0002 is issued to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders into subject solicitation. NATIONAL CONTRACT SPE2D2-23-D-0002 BUPROPION HCL ER
The contract, on USAspending
Federal procurement data the awarding office reported to FPDS, matched to this solicitation by its number.
- Recipient
- Radha Pharmaceuticals Inc.
- UEI
- C1S5SQ88KY67
- CAGE
- 8PNH3
- Vendor location
- Hauppauge, NY
- Contract
- SPE2D223D0002
- Obligated
- $0.00, potential $23,278,524
- Actions
- 4 between May 21, 2024 and September 15, 2025
- Competition
- Full and Open Competition, 5 offers received
- Set-aside reported
- No Set Aside Used.
- Described as
- 4610095053!manufacture/Distributor BR-PH
- Match
- award number SPE2D223D0002 equals the contract number; same awarding office SPE2D2 (high confidence)
- Record
- USAspending award page
Publications
Every notice SAM.gov issued under this solicitation number, oldest first. Each is a separate record on SAM.
September 13, 2024
Solicitation
Due February 15, 2022 at 3:00 PM EST. SAM.gov, notice b63a57741173444ca28e6aa0953f58af
September 15, 2025
Solicitation
Due February 15, 2022 at 3:00 PM EST. SAM.gov, notice d2713ea231544d89b653a39e3fbe278e
September 14, 2026
Award notice
Awarded to RADHA PHARMACEUTICALS Inc. Hauppauge for $23,278,524. SAM.gov, notice 885609e0a0a44507927f0fb893d641d5
Points of contact
- Kyle Lewickikyle.lewicki@dla.mil4457370977
- Jason Wrayjason.wray@dla.mil4457376304
Also open from this buyer
- Febuxostat TabletsSolicitationNAICS 325412SPE2D2-26-R-0012Closes in 7 daysSep 24
- Progesterone CapsulesSolicitationNAICS 325412SPE2D2-26-R-0015Closes in 15 daysOct 2